Cubist Pharmaceuticals, Inc. (CBST) Tops Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Operating (loss) income: 67.81M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Operating (loss) income: 67.81M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q3 EPS of $0.55, $0.10 better than the analyst estimate of $0.45. Revenue for the quarter came in at $238.2 million versus the consensus estimate of $240.04 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- Largo restructures $82.2M in debt, extending maturity to 2030
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
